A. Eelde

Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy.

S. Schulman, M. Holmström, A. Majeed, 2012, Thrombosis research.

The plasma concentration of activated protein C appears normal in patients with haemophilia

M. Blombäck, S. Schulman, J. Stenflo, 2009, Haemophilia.

A ROTEM method using APTT reagent and tissue factor as the clotting activators may better define bleeding heterogeneity in moderate or severe haemophilia A (part I: Study in plasma samples).

M. Blombäck, J. Svensson, H. Wallen, 2018, Thrombosis research.

Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome.

G. Elgue, M. Bruzelius, E. Svenungsson, 2014, Thrombosis research.

Studies of microparticles in patients with the antiphospholipid syndrome (APS)

M. Bruzelius, E. Svenungsson, K. Bremme, 2012, Lupus.

Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).

M. Bruzelius, E. Svenungsson, G. Grosso, 2017, Thrombosis research.

Validation of a composite score for clinical severity of hemophilia

M. Blombäck, J. Odeberg, S. Schulman, 2008, Journal of thrombosis and haemostasis : JTH.

Confusion around the official classification of arthropathy

S. Schulman, A. Eelde, Sam Schulman, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Total thrombin‐activatable fibrinolysis inhibitor (TAFI) antigen and pro‐TAFI in patients with haemophilia A

M. Blombäck, S. Schulman, J. Antovic, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.